Efficacy and Safety of Raltegravir (RAL) in Treatment-experienced HIV-1 Infected Adult Chinese Patients
Clinical trial NCT01201239 · UNKNOWN
Trial details
- NCT number
- NCT01201239
- Sponsor
- Shanghai Public Health Clinical Center
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2010-09-01
- Primary completion
- 2012-05-01
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.